Literature DB >> 15741205

Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients.

Daniel Teta1, Brigitte Landtwing Lüscher, Jean-Jacques Gonvers, Patrick Francioli, Olivier Phan, Michel Burnier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15741205     DOI： 10.1093/ndt/gfh747

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  10 in total

Review 1.  Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

Authors:  Kymberly D S Watt; Kelly Burak; Marc Deschênes; Les Lilly; Denis Marleau; Paul Marotta; Andrew Mason; Kevork M Peltekian; Eberhard L Renner; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

Review 2.  Hepatic disorders in chronic kidney disease.

Authors:  Fabrizio Fabrizi; Piergiorgio Messa; Carlo Basile; Paul Martin
Journal:  Nat Rev Nephrol       Date:  2010-04-13       Impact factor: 28.314

3.  Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections.

Authors:  T Eleftheriadis; V Liakopoulos; K Leivaditis; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

4.  Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.

Authors:  Jenny Sauk; Donald M Jensen; Smruti R Mohanty; Nancy Reau; K Gautham Reddy; Helen S Te
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-07

5.  Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.

Authors:  Khalid Alsaran; Alaa Sabry; Naila Shaheen
Journal:  Int Urol Nephrol       Date:  2010-05-19       Impact factor: 2.370

Review 6.  Managing chronic hepatitis C in the difficult-to-treat patient.

Authors:  Nyingi Kemmer; Guy W Neff
Journal:  Liver Int       Date:  2007-12       Impact factor: 5.828

7.  Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey.

Authors:  Sukran Kose; Alp Gurkan; Fatih Akman; Mehmet Kelesoglu; Ufuk Uner
Journal:  J Gastroenterol       Date:  2009-03-11       Impact factor: 7.527

Review 8.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Shiv K Sarin; Radha K Dhiman; Rakesh Aggarwal; Shivaram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoor; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Samir Shah; Praveen K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-24

9.  Pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C.

Authors:  Imari Mimura; Yoshitaka Ishibashi; Ryosuke Tateishi; Shinya Kaname; Toshiro Fujita
Journal:  NDT Plus       Date:  2008-06-05

10.  Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study.

Authors:  S K Agarwal; D Bhowmik; S Mahajan; S Bagchi
Journal:  Indian J Nephrol       Date:  2016 Jul-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.